Study Highlights Insurance Payment Issues for Off-label Deep Brain Stimulation
Patients who have had deep brain stimulation (DBS) to treat diseases that are not approved for the technique may not be reimbursed by an insurance company for the procedure’s costs, even though they were initially told the treatment was covered, according to a new study published in JAMA Neurology. In the…